Heart allograft survival in outbred dogs treated with procarbazine hydrochloride and antithymocyte globulin. 1985

A R Dresdale, and H Sachs, and W Thomas, and P Kurlanksy, and C Marboe, and K Reemtsma, and E A Rose

UI MeSH Term Description Entries
D008297 Male Males
D011344 Procarbazine An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease. Matulane,Natulan,Procarbazine Hydrochloride,Procarbazine Monohydrobromide,Procarbazine Monohydrochloride,Hydrochloride, Procarbazine,Monohydrobromide, Procarbazine,Monohydrochloride, Procarbazine
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006082 Graft Enhancement, Immunologic The induction of prolonged survival and growth of allografts of either tumors or normal tissues which would ordinarily be rejected. It may be induced passively by introducing graft-specific antibodies from previously immunized donors, which bind to the graft's surface antigens, masking them from recognition by T-cells; or actively by prior immunization of the recipient with graft antigens which evoke specific antibodies and form antigen-antibody complexes which bind to the antigen receptor sites of the T-cells and block their cytotoxic activity. Immunologic Enhancement of Grafts,Enhancement, Immunologic Graft,Graft Enhancement,Graft Enhancement, Immunological,Immunologic Graft Enhancement,Enhancement, Graft,Enhancement, Immunological Graft,Enhancements, Graft,Enhancements, Immunologic Graft,Enhancements, Immunological Graft,Graft Enhancements,Graft Enhancements, Immunologic,Graft Enhancements, Immunological,Immunologic Graft Enhancements,Immunological Graft Enhancement,Immunological Graft Enhancements
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000961 Antilymphocyte Serum Serum containing GAMMA-GLOBULINS which are antibodies for lymphocyte ANTIGENS. It is used both as a test for HISTOCOMPATIBILITY and therapeutically in TRANSPLANTATION. ATGAM,Antilymphoblast Globulins,Antilymphocyte Antibodies,Antilymphocyte Globulin,Lymphocytotoxic Antibodies,Anti-Thymocyte Globulin,Antilymphocyte Immunoglobulin,Antithymocyte Globulin,Antithymoglobulin,Lymphocyte Immune Globulin, Anti-Thymocyte Globulin,Lymphocyte Immune Globulin, Anti-Thymocyte Globulin (Equine),Pressimmune,Anti Thymocyte Globulin,Anti-Thymocyte Globulins,Antibodies, Antilymphocyte,Antibodies, Lymphocytotoxic,Antibody, Antilymphocyte,Antibody, Lymphocytotoxic,Antilymphoblast Globulin,Antilymphocyte Antibody,Antilymphocyte Globulins,Antilymphocyte Immunoglobulins,Antilymphocyte Serums,Antithymocyte Globulins,Antithymoglobulins,Globulin, Anti-Thymocyte,Globulin, Antilymphoblast,Globulin, Antilymphocyte,Globulin, Antithymocyte,Globulins, Anti-Thymocyte,Globulins, Antilymphoblast,Globulins, Antilymphocyte,Globulins, Antithymocyte,Immunoglobulin, Antilymphocyte,Immunoglobulins, Antilymphocyte,Lymphocyte Immune Globulin, Anti Thymocyte Globulin,Lymphocytotoxic Antibody,Serum, Antilymphocyte,Serums, Antilymphocyte
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D016027 Heart Transplantation The transference of a heart from one human or animal to another. Cardiac Transplantation,Grafting, Heart,Transplantation, Cardiac,Transplantation, Heart,Cardiac Transplantations,Graftings, Heart,Heart Grafting,Heart Graftings,Heart Transplantations,Transplantations, Cardiac,Transplantations, Heart

Related Publications

A R Dresdale, and H Sachs, and W Thomas, and P Kurlanksy, and C Marboe, and K Reemtsma, and E A Rose
January 1979, Surgical forum,
A R Dresdale, and H Sachs, and W Thomas, and P Kurlanksy, and C Marboe, and K Reemtsma, and E A Rose
October 1979, Transplantation,
A R Dresdale, and H Sachs, and W Thomas, and P Kurlanksy, and C Marboe, and K Reemtsma, and E A Rose
December 1984, Transplantation proceedings,
A R Dresdale, and H Sachs, and W Thomas, and P Kurlanksy, and C Marboe, and K Reemtsma, and E A Rose
March 1981, Transplantation proceedings,
A R Dresdale, and H Sachs, and W Thomas, and P Kurlanksy, and C Marboe, and K Reemtsma, and E A Rose
January 1987, The Journal of heart transplantation,
A R Dresdale, and H Sachs, and W Thomas, and P Kurlanksy, and C Marboe, and K Reemtsma, and E A Rose
February 1984, Journal of immunology (Baltimore, Md. : 1950),
A R Dresdale, and H Sachs, and W Thomas, and P Kurlanksy, and C Marboe, and K Reemtsma, and E A Rose
November 2018, Pediatrics,
A R Dresdale, and H Sachs, and W Thomas, and P Kurlanksy, and C Marboe, and K Reemtsma, and E A Rose
June 1988, Transplantation proceedings,
A R Dresdale, and H Sachs, and W Thomas, and P Kurlanksy, and C Marboe, and K Reemtsma, and E A Rose
August 2011, British journal of hospital medicine (London, England : 2005),
A R Dresdale, and H Sachs, and W Thomas, and P Kurlanksy, and C Marboe, and K Reemtsma, and E A Rose
May 1985, Annals of internal medicine,
Copied contents to your clipboard!